Arvinas
0 followers
ARVN
Performance
About Arvinas
Arvinas is a clinical-stage biotechnology company focused on developing targeted protein degradation therapeutics, leveraging its PROTAC platform to create transformative medicines for cancer and neurological diseases. The company operates internationally with research, development, and corporate activities centered in the United States, including New Haven roots guiding its scientific and collaborative culture. Arvinas emphasizes partnerships and a pipeline across oncology and neuroscience, translating PROTAC-driven discoveries into clinical programs. The organization highlights a mission to advance novel degraders from discovery to clinic, aiming to improve outcomes for patients with serious diseases.